We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01450514
Recruitment Status : Completed
First Posted : October 12, 2011
Last Update Posted : November 19, 2014
Sponsor:
Information provided by (Responsible Party):
PharmaNeuroBoost N.V.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2012
  Study Completion Date : December 2012